Literature DB >> 34705101

A split-face comparison of fractional erbium: YAG laser plus Kligman's formula vs. Kligman's formula monotherapy for facial melasma.

Maryam Nasimi1, Maryam Ghiasi1, Vahideh Lajevardi1, Fatemeh Nasiri1, Safoura Shakoei2.   

Abstract

Melasma is a chronic hyperpigmentation disorder. Although several treatment methods are used for patients, it remains a challenging problem for physicians. Erbium-YAG laser is one of the laser treatment methods that proved its efficacy in melasma treatment. We aimed to compare the efficacy of combining the fractional Er: YAG laser and Kligman's formula with Kligman's formula alone in the treatment of melasma. Twenty female patients with bilateral melasma were randomly treated in a split-face controlled manner with a fractional Er: YAG laser followed by Kligman's formula on one side and Kligman's formula on the other side. All patients received three laser sessions with four-week intervals. The efficacy of treatments was determined through photographs, Visioface, and Melasma Area Severity Index (MASI) score, all performed at baseline and three months after the end of laser sessions. Fractional Er: YAG laser and Kligman's formula showed a significant decrease in MASI score than Kligman's formula alone (P = 0.005). There was a significant decrease in cheek Visioface score on Er: YAG laser and Kligman's formula vs Kligman's formula (P = 0.02). However, the Patient Global Assessment Scale of both sides was not statistically significant (P = 0.23). The combination of Fractional Er: YAG laser with Kligman's formula is an effective treatment method for melasma.
© 2021. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.

Entities:  

Keywords:  Fractional Er: YAG laser; Kligman’s formula; MASI score; Melasma; Patient Global Assessment Scale

Mesh:

Substances:

Year:  2021        PMID: 34705101     DOI: 10.1007/s00403-021-02294-z

Source DB:  PubMed          Journal:  Arch Dermatol Res        ISSN: 0340-3696            Impact factor:   3.033


  13 in total

1.  Melasma treatment using an erbium:YAG laser: a clinical, immunohistochemical, and ultrastructural study.

Authors:  Enayat Attwa; Mohamed Khater; Magda Assaf; Manal Abdel Haleem
Journal:  Int J Dermatol       Date:  2014-09-30       Impact factor: 2.736

2.  Combination of Q-Switched Nd:YAG and Fractional Erbium:YAG Lasers in Treatment of Melasma: A Randomized Controlled Clinical Trial.

Authors:  Shiva Alavi; Ehsan Abolhasani; Sharin Asadi; Mohammadali Nilforoushzadeh
Journal:  J Lasers Med Sci       Date:  2017-01-08

Review 3.  Melanin pigmentary disorders: treatment update.

Authors:  Jean-Paul Ortonne; Thierry Passeron
Journal:  Dermatol Clin       Date:  2005-04       Impact factor: 3.478

4.  Reliability assessment and validation of the Melasma Area and Severity Index (MASI) and a new modified MASI scoring method.

Authors:  Amit G Pandya; Linda S Hynan; Rafia Bhore; Fransell Copeland Riley; Ian L Guevara; Pearl Grimes; James J Nordlund; Marta Rendon; Susan Taylor; Ronald W Gottschalk; Nnenna G Agim; Jean-Paul Ortonne
Journal:  J Am Acad Dermatol       Date:  2010-04-15       Impact factor: 11.527

Review 5.  Hyperpigmentation and melasma.

Authors:  D Rigopoulos; S Gregoriou; A Katsambas
Journal:  J Cosmet Dermatol       Date:  2007-09       Impact factor: 2.696

6.  Development and validation of a health-related quality of life instrument for women with melasma.

Authors:  R Balkrishnan; A J McMichael; F T Camacho; F Saltzberg; T S Housman; S Grummer; S R Feldman; M-M Chren
Journal:  Br J Dermatol       Date:  2003-09       Impact factor: 9.302

7.  Comparative study of fractional Erbium: YAG laser vs combined therapy with topical steroid as an adjuvant treatment in melasma.

Authors:  Hamza Abdel-Raouf Mohamed; Ghada Ali Nasif; Eman Saad Abdel-Azim; Mira Abd El-Fatah Ahmed
Journal:  J Cosmet Dermatol       Date:  2018-08-26       Impact factor: 2.696

8.  Fractional photothermolysis: a new concept for cutaneous remodeling using microscopic patterns of thermal injury.

Authors:  Dieter Manstein; G Scott Herron; R Kehl Sink; Heather Tanner; R Rox Anderson
Journal:  Lasers Surg Med       Date:  2004       Impact factor: 4.025

Review 9.  The use of ablative lasers in the treatment of facial melasma.

Authors:  Orlando Oliveira de Morais; Érica Freitas Lima Lemos; Márcia Carolline dos Santos Sousa; Ciro Martins Gomes; Izelda Maria Carvalho Costa; Carmen Déa Ribeiro de Paula
Journal:  An Bras Dermatol       Date:  2013 Mar-Apr       Impact factor: 1.896

10.  Fractional erbium-doped yttrium aluminum garnet laser-assisted drug delivery of hydroquinone in the treatment of melasma.

Authors:  Ashraf M Badawi; Mai Abdelraouf Osman
Journal:  Clin Cosmet Investig Dermatol       Date:  2018-01-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.